← Back|VEEVVeeva Systems Inc.
186.24 USD+3.7%Healthcare
About the company

Veeva Systems provides cloud-based software specifically designed for the life sciences industry, helping pharmaceutical and biotechnology companies manage clinical trials, regulatory submissions, sales operations and customer relationships. The company built its software on top of the Salesforce platform initially before later developing its own independent cloud infrastructure, tailoring its products specifically to the unique regulatory and operational needs of drug developers and life sciences companies. Veeva's deep specialization in a single industry vertical, rather than offering generic business software, has let it build deep domain expertise and become deeply embedded in how pharmaceutical companies manage regulated processes like clinical trials and drug approvals. The company's revenue is largely subscription-based, giving it recurring revenue tied to the ongoing software needs of its life sciences customer base, with growth driven by both new customer additions and existing customers adopting more of Veeva's expanding product suite.

Overall
6.4
Market Cap
$30.3B
P/E (ttm)
33.0
Analyst Target
244.14 USD
+31.1%
Data as of 04:26 ·